He divides his professional time between clinical and research activities. He has an active full spectrum continuity clinic. He is also active in teaching and clinical research. After residency training, Dr. Rabago received research training through a National Institutes of Health grant. His primary interest is therapy for chronic common musculoskeletal injury. Dr. Rabago is actively involved in the assessment of prolotherapy and other injection therapies for knee osteoarthritis and tendinopathy, and is the author of several peer reviewed publications in this area.